Market Cap 0.00
Revenue (ttm) 5.41B
Net Income (ttm) 50.29M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 155,500
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 0.00
Stochastic %K N/A
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Ardent Health, Inc. owns and operates a network of hospitals and clinics that provides healthcare services in the United States. The company offers general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women's services, neurology, urology, and emergency services within inpatient and ambulatory care settings. It also operates a network of ambulatory facilities and telehealth services, including primary care and specialty care clinics, amb...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 615 296 3000
Address:
340 Seven Springs Way, Suite 100, Brentwood, United States
AXLFI_HQ
AXLFI_HQ May. 6 at 11:39 PM
$ARDT Healthcare providers and medical device manufacturers report strong Q1 2026 earnings driven by product approvals, expanded commercial investments, and accelerating procedure volumes with margin expansion from operational efficiency. Learn more: https://axlfi.com/themes/220
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:25 PM
$ARDT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.28 down -6.67% YoY • Reported revenue of $1.6B up 6.99% YoY • Ardent Health is reaffirming its full-year 2026 guidance, expecting total revenue between $6.4B and $6.7B, and Adjusted EBITDA between $485M and $535M.
0 · Reply
Lemonguy
Lemonguy May. 5 at 8:22 PM
$ARDT Financial Performance Summary The Company's first quarter 2026 results included a $10.9 million gain, included in other operating expenses, from an increase in the carrying value of an investment option it holds in a privately held company. For the first quarter of 2026: Total revenue grew 7.0% year-over-year to $1,602 million, driven primarily by a 2.0% increase in adjusted admissions and a 5.5% increase in net patient service revenue per adjusted admission. Net income attributable to Ardent Health was $40 million, or $0.28 per diluted share, compared to net income attributable to Ardent Health of $41 million, or $0.29 per diluted share, in the first quarter of 2025. Adjusted EBITDA increased 26.3% year-over-year to $124 million. Excluding the $10.9 million gain discussed above, adjusted EBITDA grew 15%.
0 · Reply
Lemonguy
Lemonguy May. 5 at 8:21 PM
$ARDT https://ir.ardenthealth.com/financials/quarterly-results/default.aspx
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 9 at 4:46 AM
$ARDT Share Price: $9.34 Contract Selected: Jan 15, 2027 $10 Calls Buy Zone: $1.61 – $1.98 Target Zone: $2.76 – $3.37 Potential Upside: 62% ROI Time to Expiration: 281 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 19 at 1:00 PM
$ARDT RSI: 40.89, MACD: 0.0030 Vol: 0.25, MA20: 9.37, MA50: 9.04 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 1:00 PM
$ARDT Q4 '25 Earnings Results & Recap Ardent Health is issuing full-year 2026 guidance, expecting total revenue between $6.4B and $6.7B, and Adjusted EBITDA between $485M and $535M.
0 · Reply
Lemonguy
Lemonguy Feb. 12 at 5:13 PM
$ARDT this is incorrect.
0 · Reply
ShortSellerSavvy
ShortSellerSavvy Feb. 4 at 2:19 PM
$ARDT is a clinical-stage biotech developing therapies for cancer and inflammatory diseases; its pipeline is early-stage, representing a high-risk investment.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 3:13 AM
$ARDT RSI: 48.61, MACD: -0.2210 Vol: 0.26, MA20: 8.85, MA50: 9.04 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Latest News on ARDT
Ardent Health price target raised to $13.50 from $13 at UBS

2026-05-07T11:05:17.000Z - 6 days ago

Ardent Health price target raised to $13.50 from $13 at UBS


Ardent Health Earnings Call Transcript: Q1 2026

May 6, 2026, 10:00 AM EDT - 7 days ago

Ardent Health Earnings Call Transcript: Q1 2026


Ardent Health Reports First Quarter 2026 Results

May 5, 2026, 4:15 PM EDT - 7 days ago

Ardent Health Reports First Quarter 2026 Results


Ardent Health price target lowered to $15 from $16 at Leerink

2026-03-06T14:20:38.000Z - 2 months ago

Ardent Health price target lowered to $15 from $16 at Leerink


Ardent Health price target lowered to $13 from $14 at UBS

2026-03-06T13:56:13.000Z - 2 months ago

Ardent Health price target lowered to $13 from $14 at UBS


Ardent Health Earnings Call Transcript: Q4 2025

Mar 5, 2026, 10:00 AM EST - 2 months ago

Ardent Health Earnings Call Transcript: Q4 2025


Ardent Health reports Q4 EPS 32c, consensus 35c

2026-03-04T21:44:11.000Z - 2 months ago

Ardent Health reports Q4 EPS 32c, consensus 35c


Ardent Health sees FY26 EPS $0.90-$1.27, consensus $1.35

2026-03-04T21:43:20.000Z - 2 months ago

Ardent Health sees FY26 EPS $0.90-$1.27, consensus $1.35


Ardent Health Reports Fourth Quarter 2025 Results

Mar 4, 2026, 4:15 PM EST - 2 months ago

Ardent Health Reports Fourth Quarter 2025 Results


Ardent Health to Participate in March Investor Conferences

Mar 2, 2026, 8:00 AM EST - 2 months ago

Ardent Health to Participate in March Investor Conferences


Investors Sue Ardent Health Over Accounts Receivable Claims

2026-02-18T12:30:14.000Z - 3 months ago

Investors Sue Ardent Health Over Accounts Receivable Claims


This Stock Is Pumping Huge Cash For Its Price

Jan 16, 2026, 10:30 AM EST - 4 months ago

This Stock Is Pumping Huge Cash For Its Price


Could Ardent Health Be A Value Buy Right Now?

Jan 9, 2026, 11:05 AM EST - 4 months ago

Could Ardent Health Be A Value Buy Right Now?


Ardent Health price target lowered to $14 from $14.50 at UBS

2025-12-18T13:15:56.000Z - 5 months ago

Ardent Health price target lowered to $14 from $14.50 at UBS


Ardent Health price target lowered to $12 from $20 at Mizuho

2025-12-18T12:12:19.000Z - 5 months ago

Ardent Health price target lowered to $12 from $20 at Mizuho


Ardent Health price target lowered to $12 from $15 at JPMorgan

2025-11-24T12:20:30.000Z - 6 months ago

Ardent Health price target lowered to $12 from $15 at JPMorgan


Ardent Health Transcript: Stephens Annual Investment Conference

Nov 18, 2025, 11:00 AM EST - 6 months ago

Ardent Health Transcript: Stephens Annual Investment Conference


Ardent Health announces $50M share repurchase program

2025-11-18T14:39:51.000Z - 6 months ago

Ardent Health announces $50M share repurchase program


Ardent Health price target lowered to $13 from $20 at Mizuho

2025-11-18T11:55:21.000Z - 6 months ago

Ardent Health price target lowered to $13 from $20 at Mizuho


Ardent Health price target lowered to $14.50 from $17 at UBS

2025-11-17T22:55:16.000Z - 6 months ago

Ardent Health price target lowered to $14.50 from $17 at UBS


Ardent Health price target lowered to $16 from $23 at Leerink

2025-11-14T21:02:01.000Z - 6 months ago

Ardent Health price target lowered to $16 from $23 at Leerink


Ardent Health price target lowered to $13 from $21 at Truist

2025-11-14T13:36:18.000Z - 6 months ago

Ardent Health price target lowered to $13 from $21 at Truist


AXLFI_HQ
AXLFI_HQ May. 6 at 11:39 PM
$ARDT Healthcare providers and medical device manufacturers report strong Q1 2026 earnings driven by product approvals, expanded commercial investments, and accelerating procedure volumes with margin expansion from operational efficiency. Learn more: https://axlfi.com/themes/220
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 5 at 8:25 PM
$ARDT Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.28 down -6.67% YoY • Reported revenue of $1.6B up 6.99% YoY • Ardent Health is reaffirming its full-year 2026 guidance, expecting total revenue between $6.4B and $6.7B, and Adjusted EBITDA between $485M and $535M.
0 · Reply
Lemonguy
Lemonguy May. 5 at 8:22 PM
$ARDT Financial Performance Summary The Company's first quarter 2026 results included a $10.9 million gain, included in other operating expenses, from an increase in the carrying value of an investment option it holds in a privately held company. For the first quarter of 2026: Total revenue grew 7.0% year-over-year to $1,602 million, driven primarily by a 2.0% increase in adjusted admissions and a 5.5% increase in net patient service revenue per adjusted admission. Net income attributable to Ardent Health was $40 million, or $0.28 per diluted share, compared to net income attributable to Ardent Health of $41 million, or $0.29 per diluted share, in the first quarter of 2025. Adjusted EBITDA increased 26.3% year-over-year to $124 million. Excluding the $10.9 million gain discussed above, adjusted EBITDA grew 15%.
0 · Reply
Lemonguy
Lemonguy May. 5 at 8:21 PM
$ARDT https://ir.ardenthealth.com/financials/quarterly-results/default.aspx
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 9 at 4:46 AM
$ARDT Share Price: $9.34 Contract Selected: Jan 15, 2027 $10 Calls Buy Zone: $1.61 – $1.98 Target Zone: $2.76 – $3.37 Potential Upside: 62% ROI Time to Expiration: 281 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 19 at 1:00 PM
$ARDT RSI: 40.89, MACD: 0.0030 Vol: 0.25, MA20: 9.37, MA50: 9.04 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 5 at 1:00 PM
$ARDT Q4 '25 Earnings Results & Recap Ardent Health is issuing full-year 2026 guidance, expecting total revenue between $6.4B and $6.7B, and Adjusted EBITDA between $485M and $535M.
0 · Reply
Lemonguy
Lemonguy Feb. 12 at 5:13 PM
$ARDT this is incorrect.
0 · Reply
ShortSellerSavvy
ShortSellerSavvy Feb. 4 at 2:19 PM
$ARDT is a clinical-stage biotech developing therapies for cancer and inflammatory diseases; its pipeline is early-stage, representing a high-risk investment.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 24 at 3:13 AM
$ARDT RSI: 48.61, MACD: -0.2210 Vol: 0.26, MA20: 8.85, MA50: 9.04 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Jan. 6 at 11:43 PM
$ARDT Current Stock Price: $9.33 Contracts to trade: $10 ARDT Jan 16 2026 Call Entry: $0.18 Exit: $0.29 ROI: 60% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Crom5775
Crom5775 Jan. 2 at 4:08 PM
$ARDT new 5 day low with ugly daily candle. Switching to bearish. Looking for a bounce down to around 8.
0 · Reply
Crom5775
Crom5775 Jan. 1 at 7:23 PM
$ARDT could be a hidden gym with only 78 watchers. A P/E of about 6.2 and forward P/E is at about 6.9 is extremely low for a hospital operator. Revenue is around 6.33b and that’s a substantial footprint for a midcap healthcare operator. They have solid probability of a net income of $205M (ttm).
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 3:27 PM
UBS updates rating for Ardent Health ( $ARDT ) to Buy, target set at 14.5 → 14.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 1:11 PM
Mizuho has adjusted their stance on Ardent Health ( $ARDT ), setting the rating to Outperform with a target price of 20 → 12.
0 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 3:16 PM
JP Morgan has updated their rating for Ardent Health ( $ARDT ) to Neutral with a price target of 12.
0 · Reply
JarvisFlow
JarvisFlow Nov. 18 at 4:23 PM
Mizuho has adjusted their stance on Ardent Health ( $ARDT ), setting the rating to Outperform with a target price of 20 → 13.
0 · Reply
JarvisFlow
JarvisFlow Nov. 18 at 2:14 PM
Guggenheim has adjusted their stance on Ardent Health ( $ARDT ), setting the rating to Buy with a target price of 18 → 15.
0 · Reply
JarvisFlow
JarvisFlow Nov. 17 at 11:34 AM
Keybanc updates rating for Ardent Health ( $ARDT ) to Sector Weight.
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 3:39 PM
RBC Capital updates rating for Ardent Health ( $ARDT ) to Outperform, target set at 21 → 16.
0 · Reply
anachartanalyst
anachartanalyst Nov. 14 at 2:02 PM
$ARDT https://anachart.com/wp-content/uploads/ana_temp/1763128899_soc-img.jpg
0 · Reply
JarvisFlow
JarvisFlow Nov. 14 at 1:58 PM
Truist Securities has updated their rating for Ardent Health ( $ARDT ) to Buy with a price target of 13.
0 · Reply